Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma:multicentre East Asian and Dutch database comparison

BACKGROUND: Patients with different ethnic and genetic backgrounds may respond differently to anticancer therapies. This study aimed to assess whether patients with oesophageal squamous cell carcinoma (OSCC) treated with neoadjuvant chemoradiotherapy (nCRT) in East Asia had an inferior pathological response compared with patients treated in Northwest Europe. METHODS: Patients with OSCC who underwent nCRT according to the CROSS regimen (carboplatin and paclitaxel with concurrent 41.4 Gy radiotherapy) followed by oesophagectomy between June 2012 and April 2020 were identified from East Asian and... Mehr ...

Verfasser: Eyck, Ben M.
Gao, Xing
Yang, Yang
van der Wilk, Berend J.
Wong, Ian
Wijnhoven, Bas P. L.
Liu, Jun
Lagarde, Sjoerd M.
Ka-On, Lam
Hulshof, Maarten C. C. M.
Li, Zhigang
Law, Simon
Chao, Yin Kai
van Lanschot, J. Jan B.
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Reihe/Periodikum: Eyck , B M , Gao , X , Yang , Y , van der Wilk , B J , Wong , I , Wijnhoven , B P L , Liu , J , Lagarde , S M , Ka-On , L , Hulshof , M C C M , Li , Z , Law , S , Chao , Y K , van Lanschot , J J B & Dutch Upper Gastrointestinal Cancer Audit (DUCA) 2022 , ' Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma : multicentre East Asian and Dutch database comparison ' , British Journal of Surgery , vol. 109 , no. 12 , pp. 1312-1318 . https://doi.org/10.1093/bjs/znac314
Schlagwörter: /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being / name=SDG 3 - Good Health and Well-being
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27072793
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://pure.eur.nl/en/publications/f54ff49d-16a2-4bc1-a1a1-98def1c1feda